To further investigate the underlying immune-related biological processes and tumor-related pathways associated with the expression of PD-L2, we performed the KEGG, GOBP, and hallmark pathways enrichment analysis in the TCGA cohort. The gene discussed is PDCD1LG2; the disease is neoplasm.